Assessment of Gastric Contents in Patients Taking Glucagon-Like Peptide-1 Receptor Agonists: a Prospective Observational Cross-sectional Study
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Aspiration Risk determined by POGUS
研究概览
简要总结
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 10 Years 至 25 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Body Mass Index over 35
- •Type 2 Diabetes
- •Currently taking GLP01 RA agonist (for GLP 1 group)
- •Not taking GLP-1 RA agonist (for control group)
排除标准
- •Diagnosis of gastroparesis
- •patient refusal to participate
- •Previous gastric bypass or any other gastric surgery
- •Currently on peritoneal dialysis
- •Abdominal pathology
- •Gastro-intestinal obstruction
- •Pregnancy
研究组 & 干预措施
GLP-1
Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.
干预措施: Glucagon-Like Peptide-1 receptor agonists (Drug)
GLP-1
Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.
干预措施: Point of Care Gastric Ultrasound (Diagnostic Test)
Control
Individuals not taking GLP-1 who have a surgery scheduled with Cincinnati Children's Hospital same day surgery or endocrinology clinic and will receive a point of care gastric ultrasound.
干预措施: Point of Care Gastric Ultrasound (Diagnostic Test)
结局指标
主要结局
Aspiration Risk determined by POGUS
时间窗: Two years
Difference between control group and GLP-1 group. Measured by Gastric contents during Point of Care Gastric Ultrasound.
次要结局
未报告次要终点